The General Meeting of Oncodesign Authorises the Allocation of Oncodesign Precision Medicine (OPM) Shares to Oncodesign Shareholders
Each Oncodesign shareholder will receive one OPM share for one ONCODESIGN share held Regulatory News: Oncodesign's (Paris:ALONC) General Meeting held on September 30, 2022, authorised the
Source: finanznachrichten.de